Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: A Rochester epidemiology project population-based study in Minnesota

Journal of the American Academy of Dermatology

Volumn 72, Issue 2, 2015, Pages 302-309

  Brewer, Jerry D ^a   Shanafelt, Tait D ^a   Khezri, Farzaneh ^a   Sosa Seda, Ivette M ^a   Zubair, Adeel S ^b   Baum, Christian L ^a   Arpey, Christopher J ^a   Cerhan, James R ^a   Call, Timothy G ^a   Roenigk, Randall K ^a   Smith, Carin Y ^a   Weaver, Amy L ^a   Otley, Clark C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic lymphocytic leukemia; Immunosuppression; Malignant melanoma; Mohs micrographic surgery

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CHEMOSURGERY; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HUMAN; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; COMORBIDITY; ESOPHAGUS TUMOR; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODE METASTASIS; LYMPHOMA, NON-HODGKIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; SKIN NEOPLASMS; UNITED STATES;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMORBIDITY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHATIC METASTASIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MINNESOTA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 84922554956     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.10.028     Document Type: Article

References (27)

1. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ. 1995;310(6993):1491-1495.
2. Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1105-1108.
3. Berg JW. The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J Natl Cancer Inst. 1967;38(5): 741-752.
4. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg. 2003;29(2):129-134.
5. Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2005;53(6):1067-1071.
6. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol. 2004;140(8):985-988.
7. Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia. Dermatol Surg. 2005;31(1):38-42.
8. Levine PH, Hoover R. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Cancer Epidemiol Biomarkers Prev. 1992;1(6):515-517.
9. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267-269.
10. Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009;27(6):904-910.
11. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266-274.
12. St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ III, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc. 2012;87(2): 151-160.
13. St Sauver JL, Grossardt BR, Yawn BP, et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol. 2012;41(6): 1614-1624.
14. Bergstralh EJ, Offord KP, Kosanke JL, Augstine GA. Technical report series no. 31, PERSONYRS: a SAS procedure for person-year analyses. Rochester (MN): Department of Health Sciences Research; 1986.
15. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84(408):1074-1078.
16. Greene MH, Hoover RN, Fraumeni JF Jr. Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunologic mechanism. J Natl Cancer Inst. 1978;61(2):337-340.
17. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukemias and skin cancers. Br J Cancer. 1996;74(11):1847-1850.
18. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992;84(18):1422-1427.
19. Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol. 2004;5(3): 215-223.
20. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies: shared etiology? Int J Cancer. 1995;62(5):519-522.
21. Travis LB, Curtis RE, Boice JD Jr, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin's lymphoma. Cancer. 1991;67(7):2002-2009.
22. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst. 1993;85(23):1932-1937.
23. Aslakson CJ, Lee G, Boomer JS, Gilman-Sachs A, Kucuk O, Beaman KD. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. Am J Hematol. 1999;61(1):46-52.
24. Brewer JD. Skin cancer in patients with non-Hodgkin's lymphoma. Exp Rev Dermatol. 2010;5(5):525-533.
25. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424-431.
26. Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma. 2005;46(1):49-54.
27. Morton LM, Curtis RE, Linet MS, et al. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol. 2010;28(33):4935-4944.